claim: fda authorizes monoclonal antibodies for treatment of covid-19
evidence_1: the emergency authorization of these monoclonal antibodies administered together offers health care providers another tool in combating the pandemic, said patrizia cavazzoni, m.d., acting director of the fdas center for drug evaluation and research.